H1Innovative approaches to combat anti‐cancer drug resistance: Targeting lncRNA and autophagy

BACKGROUND: To date, standardizing clinical predictive biomarkers for assessing the response to immunotherapy remains challenging due to variations in personal genetic signatures, tumour microenvironment complexities and epigenetic onco‐mechanisms. MAIN BODY: Early monitoring of key non‐coding RNA (...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Chenming, Xie, Zijun, Duan, Shiwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576445/
https://www.ncbi.nlm.nih.gov/pubmed/37837401
http://dx.doi.org/10.1002/ctm2.1445

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576445/
https://www.ncbi.nlm.nih.gov/pubmed/37837401
http://dx.doi.org/10.1002/ctm2.1445

Ejemplares similares